Middle East & Africa Conference (MEA) 2026

Middle East & Africa Conference (MEA) 2026 is organized by Drug Information Association (DIA) and will be held from Oct 20 - 21, 2026 at ADNEC Centre Abu Dhabi, Abu Dhabi, United Arab Emirates.

Description:
Taking place at ADNEC, the conference will serve as DIA's flagship regional platform for regulatory harmonisation, reliance models, digital transformation, artificial intelligence in regulatory systems, pharmacovigilance, clinical research, market access, and sustainable healthcare solutions.

The event will bring together regulatory authorities, industry leaders, academics, patient representatives, international organisations, and healthcare stakeholders to exchange insights, strengthen partnerships, and advance more efficient, transparent, and collaborative healthcare systems across the MEA region.

Why you should attend:

• Collaborate with health authority representatives and key industry leaders from across the MEA region and contribute to shaping the future regulatory landscape.
• Connect with 300+ participants representing countries throughout the Middle East and Africa and beyond.
• Discuss new strategies and processes to be implemented across the Middle East and Africa regions.
• Learn how reliance, harmonisation initiatives, and collaboration contribute to efficient and sustainable regulatory systems throughout the region.

Who will you meet?

• Representatives from regulatory authorities across the Middle East, Africa, and international markets.
• Experts from international organisations and global regulatory initiatives.
• Industry leaders and technical experts in regulatory affairs, pharmacovigilance, digital transformation, AI, and product development.
• Global and regional pharmaceutical and healthcare stakeholders.
• Academics, patient representatives, and policy influencers contributing to healthcare regulation and innovation.

Featured topics:

• Regional Regulatory Science Developments
• International Collaboration & Reliance
• Regulatory Systems Strengthening
• Medicines Lifecycle Management
• Bringing Innovation to the MEA Region
• Capacity Building for Local Manufacturing
• The MEA Region as a Clinical Trials Hub
• Digital Transformation of Regulatory Systems
• Use of AI in the Medicinal Products Development Lifecycle
• Orphan Drug Designations & Rare Disease Policies and Designation
• Advanced Therapies
• Patient Engagement Throughout the Lifecycle